Intradermal immune response after infection with Vaccinia virus
- PMID: 16603516
- DOI: 10.1099/vir.0.81556-0
Intradermal immune response after infection with Vaccinia virus
Abstract
Although Vaccinia virus (VACV) was used to eradicate smallpox by dermal vaccination, there is little information available about the immune response induced at the vaccination site. Previously, an intradermal murine model that mimics smallpox vaccination was established. Here, this model was used to investigate which leukocytes are recruited to the infected lesion and what are the kinetics of recruitment. Data presented show that VACV infection induced the infiltration of macrophages, followed by granulocytes and lymphocytes. Up to 4 days post-infection, the major lymphocyte population was TCRgammadelta T cells, but thereafter, there was a large recruitment of CD4(+) and CD8(+) T cells. Interestingly, the majority of T cells expressed the natural killer-cell marker DX5. This report is the first to characterize the local immune response sequence to VACV infection and represents a benchmark against which the responses induced by genetically modified VACVs may be compared.
Similar articles
-
Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.J Virol. 2016 Jun 24;90(14):6557-6572. doi: 10.1128/JVI.00570-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27170749 Free PMC article.
-
Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus.PLoS One. 2011 Apr 15;6(4):e18924. doi: 10.1371/journal.pone.0018924. PLoS One. 2011. PMID: 21526210 Free PMC article.
-
Correlations between vaccinia-specific immune responses within a cohort of armed forces members.Viral Immunol. 2011 Oct;24(5):415-20. doi: 10.1089/vim.2011.0029. Epub 2011 Sep 29. Viral Immunol. 2011. PMID: 21958369 Free PMC article.
-
Monitoring of human immunological responses to vaccinia virus.Methods Mol Biol. 2004;269:243-66. doi: 10.1385/1-59259-789-0:243. Methods Mol Biol. 2004. PMID: 15114020 Review.
-
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.Future Microbiol. 2010 Feb;5(2):221-39. doi: 10.2217/fmb.09.110. Future Microbiol. 2010. PMID: 20143946 Free PMC article. Review.
Cited by
-
Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.J Immunol. 2012 Jan 1;188(1):345-57. doi: 10.4049/jimmunol.1101703. Epub 2011 Dec 2. J Immunol. 2012. PMID: 22140255 Free PMC article.
-
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence.J Gen Virol. 2012 Oct;93(Pt 10):2098-2108. doi: 10.1099/vir.0.045070-0. Epub 2012 Jul 12. J Gen Virol. 2012. PMID: 22791606 Free PMC article.
-
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.J Virol. 2009 Apr;83(8):3684-95. doi: 10.1128/JVI.02042-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211768 Free PMC article.
-
Initiation of primary anti-vaccinia virus immunity in vivo.Immunol Res. 2007;37(2):113-33. doi: 10.1007/BF02685894. Immunol Res. 2007. PMID: 17695247 Review.
-
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.J Gen Virol. 2008 Oct;89(Pt 10):2377-2387. doi: 10.1099/vir.0.2008/004895-0. J Gen Virol. 2008. PMID: 18796705 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials